Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer
US10174117B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2014 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Jun 11, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.